Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients
Open Access
- 1 April 2010
- journal article
- review article
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. 6 (1) , 145-150
Abstract
Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients Barbara Błaszczyk1,2, Stanisław J Czuczwar3,41Department of Neurology, Neuropsychiatric Hospital, Kielce, Poland; 2Faculty of Health Sciences, High School of Economics and Law, Kielce, Poland; 3Department of Pathophysiology, Medical University, Lublin, Poland; 4Department of Physiopathology, Institute of Agricultural Medicine, Lublin, Poland Epilepsy is a frequent, chronic disease demanding long-term medication with antiepileptic drugs (AEDs). When slow release formulations of AEDs are used the chance of compliance and control of seizures is increased. Lamotrigine (LTG) is a broad spectrum antiepileptic drug (AED), effective against both generalized and partial seizures. Its immediate-release formulation (LTG-IR) requires twice-daily dosing. In contrast, an extended-release formulation (LTG-XR) may be given once daily, providing a flatter dose-concentration curve with apparently lower maximum serum levels. Simplified dosing positively affects compliance and LTG-XR has a similar profile of efficacy and tolerability to LTG-IR. Rashes, including Stevens–Johnson syndrome, are the most serious adverse effect impacting 0.8% of pediatric patients. Thus, LTG-XR should be discontinued upon the appearance of rash.Keywords: epilepsy, antiepileptic drugs, extended-release, lamotrigine, adverse reactions, tolerability, pharmacokineticsKeywords
This publication has 30 references indexed in Scilit:
- The teratogenic risk of antiepileptic drug polytherapyEpilepsia, 2010
- Seizure frequency in pregnant women treated with lamotrigine monotherapyEpilepsia, 2009
- Once-daily lamotrigine extended release for epilepsy managementExpert Review of Neurotherapeutics, 2009
- Managing Epilepsy in Women of Childbearing AgeDrug Safety, 2009
- Isobolographic characterization of interactions of retigabine with carbamazepine, lamotrigine, and valproate in the mouse maximal electroshock-induced seizure modelNaunyn-Schmiedeberg's Archives of Pharmacology, 2008
- Lamotrigine extended-release as adjunctive therapy for partial seizuresNeurology, 2007
- Non-epilepsy uses of antiepilepsy drugs.2006
- Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy SocietyEpilepsia, 2004
- Effect of Gabapentin on the Anticonvulsant Activity of Antiepileptic Drugs against Electroconvulsions in Mice: An Isobolographic AnalysisEpilepsia, 2002
- Acute Effects of Lamotrigine (BW430C) in Persons With EpilepsyEpilepsia, 1986